Amneal Pharma Says FDA Approves Lisdexamfetamine Dimesylate Capsules

RTTNews | 709 gün önce
Amneal Pharma Says FDA Approves Lisdexamfetamine Dimesylate Capsules

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced Wednesday it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration for lisdexamfetamine dimesylate capsules, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg.

Lisdexamfetamine dimesylate capsules is a generic version of Vyvanse. This ADHD product is currently on the U.S. FDA shortage product list, and Amneal has already begun supplying product to the market.

Lisdexamfetamine dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and above and for adults with moderate to severe Binge Eating Disorder.

According to IQVIA, U.S. annual sales for lisdexamfetamine dimesylate for the 12 months ended June 2023 were $5.3 billion.

Etiketler: AMRX
read more
Amneal Pharma Says FDA Accepts For Review ANDA For Naloxone Hydrochloride Nasal Spray

Amneal Pharma Says FDA Accepts For Review ANDA For Naloxone Hydrochloride Nasal Spray

Essential medicines company Amneal Pharmaceuticals, Inc. (AMRX) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New Drug Application (ANDA) for naloxone hydrochloride nasal spray, USP, 4mg, which is the generic version of Narcan and is used in the treatment of a known or suspected opioid overdose emergency.
RTTNews | 897 gün önce
U.S. Industrial Production Pulls Back Slightly In July

U.S. Industrial Production Pulls Back Slightly In July

A report released by the Federal Reserve on Friday showed a modest decrease by U.S. industrial production in the month of July. The Fed said industrial production edged down by 0.1 percent in July after climbing by an upwardly revised 0.4 percent in June. Economists had expected industrial production to come in unchanged.
RTTNews | 10 dakika önce
New York Manufacturing Index Unexpectedly Climbs To Nine-Month High In August

New York Manufacturing Index Unexpectedly Climbs To Nine-Month High In August

The Federal Reserve Bank of New York released a report on Friday showing regional manufacturing activity unexpectedly grew at a faster rate in the month of August. The New York Fed said its general business conditions index climbed to 11.9 in August from 5.5 in July, with a positive reading indicating growth. Economists had expected the index to fall to 0.5.
RTTNews | 34 dakika önce
U.S. Import Price Growth Exceeds Estimates In July

U.S. Import Price Growth Exceeds Estimates In July

The Labor Department released a report on Friday showing import prices in the U.S. increased by more than expected in the month of July. The report said import prices climbed by 0.4 percent in July after a downwardly revised 0.1 percent dip in June. Economists had expected import prices to inch up by 0.1 percent, matching the 0.1 percent uptick originally reported for the previous month.
RTTNews | 1s 8 dakika önce
U.S. Retail Sales Climb 0.5% In July, In Line With Estimates

U.S. Retail Sales Climb 0.5% In July, In Line With Estimates

A report released by the Commerce Department on Friday showed retail sales in the U.S. increased in line with economist estimates in the month of July. The Commerce Department said retail sales climbed by 0.5 percent in July after jumping by an upwardly revised 0.9 percent in June.
RTTNews | 1s 41 dakika önce